A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.

Subjects

Subjects :

Adult
CD4 Lymphocyte Count
Drug Therapy, Combination
Female
HIV Protease Inhibitors administration & dosage
Humans
Lamivudine administration & dosage
Lamivudine therapeutic use
Lopinavir
Male
Nevirapine administration & dosage
Nevirapine therapeutic use
Pyrimidinones administration & dosage
Pyrimidinones therapeutic use
Reverse Transcriptase Inhibitors administration & dosage
Ritonavir administration & dosage
Ritonavir therapeutic use
Viral Load
Zidovudine administration & dosage
Zidovudine therapeutic use
HIV Infections drug therapy
HIV Protease Inhibitors therapeutic use
Reverse Transcriptase Inhibitors therapeutic use

Details

Language :

English

ISSN :

1525-4135

Volume :

50

Issue :

3

Database :

MEDLINE

Journal :

Journal of acquired immune deficiency syndromes (1999)

Publication Type :

Report

Accession number :

19242263

Full Text :

https://doi.org/10.1097/QAI.0b013e3181938fc9